McDade E, Llibre-Guerra JJ, Holtzman DM, Morris JC, Bateman RJ. The informed road map to prevention of Alzheimer disease: a call to arms. Mol Neurodegener. 2021;16(1):49.
Article PubMed PubMed Central Google Scholar
Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286(5440):735–41.
Article CAS PubMed Google Scholar
Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, et al. Identification of a novel aspartic protease (asp 2) as beta-secretase. Mol Cell Neurosci. 1999;14(6):419–27.
Article CAS PubMed Google Scholar
Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 1999;402(6761):537–40.
Article CAS PubMed Google Scholar
Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature. 1999;402(6761):533–7.
Article CAS PubMed Google Scholar
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer's disease. Lancet. 2021;397(10284):1577–90.
Article CAS PubMed PubMed Central Google Scholar
Zhai K, Huang Z, Huang Q, Tao W, Fang X, Zhang A, et al. Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells. Nature Cancer. 2021;2(11):1136–51.
Article CAS PubMed PubMed Central Google Scholar
Voytyuk I, Mueller SA, Herber J, Snellinx A, Moechars D, van Loo G, et al. BACE2 distribution in major brain cell types and identification of novel substrates. Life Sci Alliance. 2018;1(1):e201800026. https://doi.org/10.26508/lsa.201800026.
McDade E, Voytyuk I, Aisen P, Bateman RJ, Carrillo MC, De Strooper B, et al. The case for low-level BACE1 inhibition for the prevention of Alzheimer disease. Nat Rev Neurol. 2021;17(11):703–14.
Henley D, Raghavan N, Sperling R, Aisen P, Raman R, Romano G. Preliminary results of a trial of Atabecestat in preclinical Alzheimer's disease. N Engl J Med. 2019;380(15):1483–5.
Wessels AM, Lines C, Stern RA, Kost J, Voss T, Mozley LH, et al. Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease. Alzheimers Dement. 2020;16(11):1483–92.
Kuhn PH, Koroniak K, Hogl S, Colombo A, Zeitschel U, Willem M, et al. Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J. 2012;31(14):3157–68.
Article CAS PubMed PubMed Central Google Scholar
Stutzer I, Selevsek N, Esterhazy D, Schmidt A, Aebersold R, Stoffel M. Systematic proteomic analysis identifies beta-site amyloid precursor protein cleaving enzyme 2 and 1 (BACE2 and BACE1) substrates in pancreatic beta-cells. J Biol Chem. 2013;288(15):10536–47.
Article CAS PubMed PubMed Central Google Scholar
Tushaus J, Muller SA, Kataka ES, Zaucha J, Sebastian Monasor L, Su M, et al. An optimized quantitative proteomics method establishes the cell type-resolved mouse brain secretome. EMBO J. 2020;39(20):e105693.
Article PubMed PubMed Central Google Scholar
Hemming ML, Elias JE, Gygi SP, Selkoe DJ. Identification of β-secretase (BACE1) substrates using quantitative proteomics. PLoS One. 2010;4(12):e8477.
Barão S, Gärtner A, Leyva-Díaz E, Demyanenko G, Munck S, Vanhoutvin T, et al. Antagonistic effects of BACE1 and APH1B-γ-secretase control axonal guidance by regulating growth cone collapse. Cell Rep. 2015;12(9):1367–76.
Article PubMed PubMed Central Google Scholar
Barão S, Moechars D, Lichtenthaler SF, De Strooper B. BACE1 physiological functions May limit its use as therapeutic target for Alzheimer's disease. Trends Neurosci. 2016;39(3):158–69.
Cheret C, Willem M, Fricker FR, Wende H, Wulf-Goldenberg A, Tahirovic S, et al. Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles. EMBO J. 2013;32(14):2015–28.
Article CAS PubMed PubMed Central Google Scholar
Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, et al. The beta-secretase BACE1 in Alzheimer's disease. Biol Psychiatry. 2021;89(8):745–56.
Article CAS PubMed Google Scholar
Hitt B, Riordan SM, Kukreja L, Eimer WA, Rajapaksha TW, Vassar R. β-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects. J Biol Chem. 2012;287(46):38408–25.
Article CAS PubMed PubMed Central Google Scholar
Dislich B, Wohlrab F, Bachhuber T, Muller SA, Kuhn PH, Hogl S, et al. Label-free quantitative proteomics of mouse cerebrospinal fluid detects beta-site APP cleaving enzyme (BACE1) protease substrates in vivo. Mol Cell Proteomics. 2015;14(10):2550–63.
Article CAS PubMed PubMed Central Google Scholar
Muller T, Braud S, Juttner R, Voigt BC, Paulick K, Sheean ME, et al. Neuregulin 3 promotes excitatory synapse formation on hippocampal interneurons. EMBO J. 2018;37(17).
Ou-Yang MH, Kurz JE, Nomura T, Popovic J, Rajapaksha TW, Dong H, et al. Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice. Sci Transl Med. 2018;10(459).
Pigoni M, Wanngren J, Kuhn P-H, Munro KM, Gunnersen JM, Takeshima H, et al. Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons. Mol Neurodegener. 2016;11(1):67.
Article PubMed PubMed Central Google Scholar
Zhou L, Barão S, Laga M, Bockstael K, Borgers M, Gijsen H, et al. The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo. J Biol Chem. 2012;287(31):25927–40.
Article CAS PubMed PubMed Central Google Scholar
Lichtenthaler SF, Lemberg MK. Fluhrer R: proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments. EMBO J. 2018;37(15).
Kennedy ME, Stamford AW, Chen X, Cox K, Cumming JN, Dockendorf MF, et al. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients. Sci Transl Med. 2016;8(363):363ra150.
Mandal M, Wu Y, Misiaszek J, Li G, Buevich A, Caldwell JP, et al. Structure-based Design of an Iminoheterocyclic β-site amyloid precursor protein cleaving enzyme (BACE) inhibitor that lowers central Aβ in nonhuman Primates. J Med Chem. 2016;59(7):3231–48.
Article CAS PubMed Google Scholar
Dobrowolska JA, Michener MS, Wu G, Patterson BW, Chott R, Ovod V, et al. CNS amyloid-beta, soluble APP-alpha and -beta kinetics during BACE inhibition. J Neurosci. 2014;34(24):8336–46.
Article PubMed PubMed Central Google Scholar
Kirik D, Annett LE, Burger C, Muzyczka N, Mandel RJ, Björklund A. Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein: a new primate model of Parkinson's disease. Proc Natl Acad Sci. 2003;100(5):2884–9.
Article CAS PubMed PubMed Central Google Scholar
Haanstra KG, Jagessar SA, Bauchet A-L, Doussau M, Fovet C-M, Heijmans N, et al. Induction of experimental autoimmune encephalomyelitis with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund’s adjuvant in three non-human primate species. J NeuroImmune Pharmacol. 2013;8(5):1251–64.
Article PubMed PubMed Central Google Scholar
Stevens SL, Liu T, Bahjat FR, Petyuk VA, Schepmoes AA, Sontag RL, et al. Preconditioning in the Rhesus macaque induces a proteomic signature following cerebral ischemia that is associated with neuroprotection. Transl Stroke Res. 2019;10(4):440–8.
Article CAS PubMed Google Scholar
Gibbs RA, Rogers J, Katze MG, Bumgarner R, Weinstock GM, Mardis ER, et al. Evolutionary and biomedical insights from the Rhesus macaque genome. Science. 2007;316(5822):222–34.
Article CAS PubMed Google Scholar
Gilberto DB, Michener MS, Smith BE, Szczerba PJ, Holahan MA, Gray TL, et al. Chronic collection of cerebrospinal fluid from Rhesus macaques (Macaca mulatta) with cisterna magna ports: update on refinements. Comp Med. 2022;72(1):45–9.
Article CAS PubMed PubMed Central Google Scholar
Eric H, Rebecca FR, Amarallys C, Lary CW. Nonhuman primate models of Alzheimer-like cerebral Proteopathy. Curr Pharm Des. 2012;18(8):1159–69.
Geguchadze RN, Coe CL, Lubach GR, Clardy TW, Beard JL, Connor JR. CSF proteomic analysis reveals persistent iron deficiency-induced alterations in non-human primate infants. J Neurochem. 2008;105(1):127–36.
Article CAS PubMed Google Scholar
Patton SM, Coe CL, Lubach GR, Connor JR. Quantitative proteomic analyses of cerebrospinal fluid using iTRAQ in a primate model of iron deficiency anemia. Dev Neurosci. 2012;34(4):354–65.
留言 (0)